1. Home
  2. BIO vs CMA Comparison

BIO vs CMA Comparison

Compare BIO & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CMA
  • Stock Information
  • Founded
  • BIO 1952
  • CMA 1849
  • Country
  • BIO United States
  • CMA United States
  • Employees
  • BIO N/A
  • CMA N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CMA Major Banks
  • Sector
  • BIO Industrials
  • CMA Finance
  • Exchange
  • BIO Nasdaq
  • CMA Nasdaq
  • Market Cap
  • BIO 9.5B
  • CMA 8.6B
  • IPO Year
  • BIO N/A
  • CMA N/A
  • Fundamental
  • Price
  • BIO $343.61
  • CMA $62.02
  • Analyst Decision
  • BIO Strong Buy
  • CMA Hold
  • Analyst Count
  • BIO 4
  • CMA 24
  • Target Price
  • BIO $381.50
  • CMA $61.35
  • AVG Volume (30 Days)
  • BIO 182.3K
  • CMA 1.8M
  • Earning Date
  • BIO 10-30-2024
  • CMA 10-18-2024
  • Dividend Yield
  • BIO N/A
  • CMA 4.58%
  • EPS Growth
  • BIO N/A
  • CMA N/A
  • EPS
  • BIO N/A
  • CMA 4.02
  • Revenue
  • BIO $2,562,604,000.00
  • CMA $3,161,000,000.00
  • Revenue This Year
  • BIO N/A
  • CMA N/A
  • Revenue Next Year
  • BIO $4.49
  • CMA $4.72
  • P/E Ratio
  • BIO N/A
  • CMA $15.45
  • Revenue Growth
  • BIO N/A
  • CMA N/A
  • 52 Week Low
  • BIO $261.59
  • CMA $37.40
  • 52 Week High
  • BIO $364.24
  • CMA $66.06
  • Technical
  • Relative Strength Index (RSI)
  • BIO 55.67
  • CMA 58.56
  • Support Level
  • BIO $338.84
  • CMA $57.57
  • Resistance Level
  • BIO $350.53
  • CMA $66.06
  • Average True Range (ATR)
  • BIO 7.98
  • CMA 1.55
  • MACD
  • BIO 0.24
  • CMA 0.29
  • Stochastic Oscillator
  • BIO 67.74
  • CMA 54.20

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CMA Comerica Incorporated

With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.

Share on Social Networks: